journal article·2017-04-03Open access

Exemestane encapsulated vitamin E-TPGS–polymeric nanoparticles: preparation, optimization, characterization, andin vitrocytotoxicity assessment

Brahmeshwar Mishra, Ravi Padaliya, Ravi R. Patel

Abstract

The objective of the present study was to formulate and optimize exemestane (EXM) encapsulated vitamin E-TPGS–poly-ɛ-caprolactone based polymeric nanoparticles (TPGS–PCLNPs) for enhancing its anticancer efficacy. The 23 factorial design was employed to investigate the combined influence of formulation and process variables on properties of TPGS–PCLNPs, prepared by nanoprecipitation method. The physicochemical characterization revealed the encapsulation of EXM in amorphous form without any interaction inside spherical shaped TPGS–PCLNPs. In vitro cytotoxicity study on MCF-7 breast cancer cells exhibited enhanced cytotoxicity of EXM by encapsulating in TPGS–PCLNPs. The TPGS–PCLNPs can serve as potential delivery vehicle for EXM to improve its therapeutic efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · biodegradable polymer synthesis and properties · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, Indian Institute of Technology (Banaras Hindu University), Varanasi, India

References (47)

Show source-provided references
1. Ahdavi HM · J Appl Polym Sci · 2010 · 116 · 52810.1002/app.31595 ↗
2. 10.1016/j.colsurfb.2013.07.03610.1016/j.colsurfb.2013.07.036 ↗
3. 10.1517/17425247.2014.91707610.1517/17425247.2014.917076 ↗
4. 10.3109/03639045.2015.106494110.3109/03639045.2015.1064941 ↗
5. 10.1166/asl.2014.547810.1166/asl.2014.5478 ↗
6. 10.1016/j.carbpol.2015.04.06210.1016/j.carbpol.2015.04.062 ↗
7. 10.1016/j.jconrel.2011.09.06410.1016/j.jconrel.2011.09.064 ↗
8. 10.1023/A:101500050362910.1023/A:1015000503629 ↗
9. 10.1016/S0142-9612(00)00040-510.1016/S0142-9612(00)00040-5 ↗
10. 10.1016/S0168-3659(00)00364-310.1016/S0168-3659(00)00364-3 ↗
11. Fessi H · Int J Pharm · 1989 · 55 · R110.1016/0378-5173(89)90281-0 ↗
12. 10.1016/S0168-3659(02)00212-210.1016/S0168-3659(02)00212-2 ↗
13. 10.1186/s40199-014-0087-010.1186/s40199-014-0087-0 ↗
14. 10.3109/03639045.2015.109349610.3109/03639045.2015.1093496 ↗
15. 10.1023/B:PHAM.0000036917.75634.be10.1023/B:PHAM.0000036917.75634.be ↗
16. 10.1056/NEJM19920730327050510.1056/NEJM199207303270505 ↗
17. Johannessen DC · Clin Cancer Res · 1997 · 3 · 1101
18. 10.1155/2013/34809510.1155/2013/348095 ↗
19. 10.3109/10837450.2015.110898310.3109/10837450.2015.1108983 ↗
20. 10.1039/C5RA26674B10.1039/C5RA26674B ↗
21. 10.1166/asl.2014.548310.1166/asl.2014.5483 ↗
22. 10.1007/s12645-013-0037-410.1007/s12645-013-0037-4 ↗
23. 10.1023/A:102501750237910.1023/A:1025017502379 ↗
24. Leroux JC · 1996 · 535
25. 10.1016/j.cherd.2012.02.01010.1016/j.cherd.2012.02.010 ↗
26. 10.1136/bmj.321.7261.62410.1136/bmj.321.7261.624 ↗
27. 10.1016/j.nano.2009.04.00810.1016/j.nano.2009.04.008 ↗
28. 10.1016/S0168-3659(02)00320-610.1016/S0168-3659(02)00320-6 ↗
29. 10.1023/B:PHAM.0000003387.15428.4210.1023/B:PHAM.0000003387.15428.42 ↗
30. 10.1016/0378-5173(94)90039-610.1016/0378-5173(94)90039-6 ↗
31. 10.3109/02652048.2016.114481910.3109/02652048.2016.1144819 ↗
32. 10.1016/j.ijbiomac.2015.11.08410.1016/j.ijbiomac.2015.11.084 ↗
33. 10.1039/C5RA12732G10.1039/C5RA12732G ↗
34. 10.1166/asl.2014.547310.1166/asl.2014.5473 ↗
35. 10.1016/j.biomaterials.2008.09.05610.1016/j.biomaterials.2008.09.056 ↗
36. 10.1016/S0168-3659(96)01475-710.1016/S0168-3659(96)01475-7 ↗
37. 10.1016/S0140-6736(11)61539-010.1016/S0140-6736(11)61539-0 ↗
38. 10.1016/j.actbio.2011.07.02510.1016/j.actbio.2011.07.025 ↗
39. 10.1021/am900584r10.1021/am900584r ↗
40. 10.1023/A:102572710381110.1023/A:1025727103811 ↗
41. 10.1038/nprot.2006.17910.1038/nprot.2006.179 ↗
42. 10.1016/j.uct.2009.07.00110.1016/j.uct.2009.07.001 ↗
43. 10.1208/s12249-010-9519-410.1208/s12249-010-9519-4 ↗
44. 10.1016/j.ijpharm.2010.07.04610.1016/j.ijpharm.2010.07.046 ↗
45. 10.1016/j.jconrel.2005.05.01410.1016/j.jconrel.2005.05.014 ↗
46. 10.2217/nnm.12.11710.2217/nnm.12.117 ↗
47. 10.1016/j.biomaterials.2006.03.00610.1016/j.biomaterials.2006.03.006 ↗